Patent PT-79371-A (PT)
Title: Process for the manufacture of novel phenoxypropanolamines of novel intermediates therefor and of pharmaceutical compositions containing the same
Inventor: ALIG LEO
IPC: C07C229/38
Filed: 1984-10-18
Abstract: 1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Phenoxypropanolamines of the formula   see diagramm : EP0140243,P23,F1   wherein n is the number 1 or 2, R is hydrogen, lower-alkanoyl or phenyl-lower-alkanoyl, X**1 is phenoxymethyl optionally monofluorinated or mono-chlorinated in the ortho-position, X**2 is lower-alkyl, phenoxymethyl optionally monofluorinated or mono-chlorinated in the ortho-position or phenyl optionally monosubstituted by fluorine, chlorine, trifluoromethyl or lower-alkoxy, Y is hydrogen or methyl, Z is a group of the formula   see diagramm : EP0140243,P24,F1   or   see diagramm : EP0140243,P24,F2   R**1 is optionally N-mono-lower-alkylated or N-di-lower-alkylated aminomethyl or a residue -(C(O)R**2 , -C(R**3 ) = CH-(CH2 )m -C(O)R**2 , -C(H,R**3 )-(CH2 )m+1 -C(O)R**2 , -C(H,R**3 )-(CH2 )p -OH or -C(R**3 ) = CH-C(CH3 ) = CH-COOCH3 , R**11 is hydroxy, lower-alkanoyloxy, sulphamoyl, benzyloxy or phenoxy optionally ring-substituted by fluorine, chlorine, trifluoromethyl, lower-alkyl or lower-alkoxy, or a group R**1 , -O-(CH2 )q -OH, -O-(CH2 )q -O-(CH2 )t -R**5 or   see diagramm : EP0140243,P24,F3   R**2 is hydroxy, lower-alkyl, lower-alkoxy, dimethylaminoethoxy, lower-alkoxycarbonylethyl or optionally mono-lower alkylated or di-lower alkylated amino, R**3 is hydrogen or methyl, R**5 is hydrogen, lower-alkyl or phenyl, R**6 is lower-alkyl or phenyl optionally para-substituted by fluorine, chlorine, lower-alkyl or lower-alkoxy, m and p are whole numbers of 0 to 6, v is a whole number of 2 to 4, q and t are whole numbers of 1 to 6, and physiologically compatible salts thereof. 1. Claims (for the Contracting State AT) A process for the manufacture of phenoxypropanolamines of the formula   see diagramm : EP0140243,P25,F1   wherein n is the number 1 or 2, R is hydrogen, lower-alkanoyl or phenyl-lower-alkanoyl, X**1 is phenoxymethyl optionally mono-fluorinated or mono-chlorinated in the ortho-position, X**2 is lower-alkyl, phenoxymethyl optionally monofluorinated or mono-chlorinated in the orthoposition or phenyl optionally monosubstituted by fluorine, chlorine, trifluoromethyl or lower-alkoxy, Y is hydrogen or methyl, Z is a group of the formula   see diagramm : EP0140243,P25,F2   or   see diagramm : EP0140243,P25,F3   R**1 is optionally N-mono-lower-alkylated or N-di-lower-alkylated aminomethyl or a residue -C(O)R**2 , -C(R**3 ) = CH-(CH2 )m -C(O)R**2 , -C(H,R**3 )-(CH2 )m+1 -C(O)R**2 , -C(H,R**3 )-(CH2 )p -OH or -C(R**3 ) = CH-C(CH3 ) = CH-COOCH3 , R**11 is hydroxy, lower-alkanoyloxy, sulphamoyl, benzyloxy or phenoxy optionally ring-substituted by fluorine, chlorine, trifluoromethyl, lower-alkyl or lower-alkoxy, or a group R**1 , -O-(CH2 )q -OH, -O-(CH2 )q -O-(CH2 )t -R**5 or   see diagramm : EP0140243,P26,F1   R**2 is hydroxy, lower-alkyl, lower-alkoxy, dimethylaminoethoxy, lower-alkoxycarbonylethyl or optionally mono-lower alkylated or di-lower alkylated amino, R**3 is hydrogen or methyl, R**5 is hydrogen, lower-alkyl or phenyl, R**6 is lower-alkyl or phenyl optionally para-substituted by fluorine, chlorine, lower-alkyl or lower-alkoxy, m and p are whole numbers of 0 to 6, v is a whole number of 2 to 4, q and t are whole numbers of 1 to 6, and of physiologically compatible salts thereof, characterized by a) reacting an epoxide of the formula   see diagramm : EP0140243,P26,F2   or a beta-keto halide of the formula   see diagramm : EP0140243,P26,F3   with a primary amine of the formula   see diagramm : EP0140243,P26,F4   or a secondary amine of the formula   see diagramm : EP0140243,P26,F5   wherein in formulae II-V n, Y and Z the above significance, Hal is halogen, one of the groups X**3 and X**4 is a group X**1 and the other is a group X**2, whereby further X**3 is a group X**1 when a compound of formula II or III is reacted with a compound of formula IV, and reducing a X**1 -C(O)- or X**2 -C(O)- group in a compound obtained to a X**1 -CHOH- or X**2 -CHOH- group, b) if desired, functionally modifying a reactive substituent present in a group Z of a compound of formula I, c) if desired, alkanoylating or phenalkanoylating the hydroxy groups present in a diol of formula I, and d) if desired, converting a compound of formula I into a salt.